Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials

Thind, M., Zareba, W., Atar, D., Crijns, H. J. G. M., Zhu, J., Pak, H., Reiffel, J., Ludwigs, U., Wieloch, M., Stewart, J., & Kowey, P. (2022). Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS‐ADONIS trials. Clinical Cardiology, 45(1), 101–109. Portico. https://doi.org/10.1002/clc.23765
Authors:
Munveer Thind
Wojciech Zareba
Dan Atar
Harry J G M Crijns
Jun Zhu
Hui-Nam Pak
James Reiffel
Ulf Ludwigs
Mattias Wieloch
John Stewart
Peter Kowey
Affiliated Authors:
James Reiffel
Author Keywords:
antiarrhythmic drugs
atrial fibrillation
atrial flutter
chronic kidney disease
dronedarone
renal function
atrial fibrillation/atrial flutter
Publication Type:
Article
Unique ID:
10.1002/clc.23765
PMID:
Publication Date:
Data Source:
PubMed

Record Created: